Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
GLAUCOMA UPDATE Managing The Glaucoma Suspect – When Do I Refer? DR RAJIV SHAH EASTWOOD EYE SURGERY Glaucoma • Glaucoma is the most common cause of irreversible blindness worldwide • Often bilateral and mostly asymptomatic • Early detection and intervention will reduce incidence of blindness and visual morbidity • Well established risk factors, clinical findings, investigations and treatments Glaucoma Suspect • Many people are labelled as Glaucoma Supects (GS) • Usually those with borderline IOP, family history or questionable disc/field changes • Aren’t enough eye doctors in the community to see them all • The optometrist is often the carer for the GS • Patients have faith in their healthcare providers and therefore we need to know how to manage and when to refer (this applies for all) Glaucoma Suspects • Is it acceptable to follow up GS with serial white on white fields? • Once a field defect is seen many nerve fibres have been lost (Klein et al.,IOVS 2004; 45:5962) • Ideally, in the 21st century we need to aim to detect damage at preperimetric levels • Not always easy – compliance and cost issues, keeping up with technology • There are some simple and effective ways Who to screen? • • • • • Everyone? Those with family history? Raised pressure? Those above 40? All of the above It doesn’t take a long time to look at a disc even through an undilated pupil Key Questions • The optometrist is often the first port of call. Role as the eye GP? • Family history – blindness, laser/surgeries, eyedrops, glaucoma or ocular hypertension? • Isn’t always reliable • Disregard beyond two generations and beyond first cousins/ blood uncles and aunts Key Questions • Past ocular history? – Previous trauma – Previous LASIK / other laser surgery (PI/ALT), other incisional surgery and complications – Eyedrops – Refraction, amblyopia Key Questions • General Health – – – – – – Asthma Hypertension Diabetes Sleep Apnea Migraine Neurological problems (CVA, tumour) – can cause field defects – Medications – antidepressants, sulphonamides, steroids (inhaled, nasal, topical, systemic) Key Questions • Other risk factors – Age – Racial group – Consanguinity – Occupation – Driving – Cigarettes / alcohol – Living arrangements / carers Examination • • • • • Aided and unaided VA RAPD CCT IOP (Goldmann applanation). Diurnal? AC depth (Van Herrick > ¼ cornea thickness). Gonioscopy ? • Iris heterochromia, PXF, PDS • Look for laser iridotomy, iridoplasty, PS, Glaukomflecken, cataract (phacomorphic) • DILATE (very, very small risk of AAC) CCT • Central corneal thickness (CCT) measurements must be performed in all glaucoma suspects. Those with thinner corneas (<500 microns) have a greater risk of glaucoma development and progression (OHTS Study). • MUST BE CENTRAL! Phacomorphic Glaucoma IOP • Which method? – – – – NCT Applanation Tonopen Percussion • Artifacts – lid pressure, breath holding, upgaze, lash, blepharospasm, too much fluorescein, astigmatism, corneal scar, nystagmus • At what level is treatment mandatory? IOP • There are a large percentage (30% at least) of patients who have glaucoma with normal pressures (NPG). In some populations (Japan, Korea) NPG incidence is 2-3 times POAG. • The end organ damage is the same (disc cupping) but the natural history and prognosis may differ. There is a stronger association with vascular disorders ( migraine, nocturnal hypotension, Raynauds disease) Ocular Hypertension • Ocular hypertension when IOP > 21mmHg • The most significant risk factor for glaucoma development • Different techniques/examiners can get differing IOP • OHTS looked at people with IOP 24-32 • Probability of progression in the treated group (4.4%) was half that of observation group (9.5%) at 5 years • 90% didn’t progress at 5 years • Role of corneal thickness Does lowering IOP help? • No evidence until late 1990’s • Early Manifest Glaucoma Trial (EMGT) • Compared immediate treatment v no or delayed treatment on newly diagnosed POAG patients • Treated group had less frequent and later progression at 6 years • High IOP risk of vascular occlusions Examination • • • • • • • • Disc size – must identify the limits of the disc C/D Notching? General rim thinning? ISNT rule PPA? Pallor? Colour? Disc haem? RNFL defects Other disease – lid height, ARMD, DR, peripheral retina abnormalities, RP, Laser scars, disc drusen, tilted discs, disc pits • THESE CAN CAUSE FIELD DEFECTS FORGE : 5 Rules of disc assessment (Focusing Ophthalmology on Reframing Glaucoma Evaluation) Disc Size (Fingeret et al, Optometry 2005) Disc Anomalies (Fingeret et al) ISNT Rule and NFLD (Fingeret et al) PPA • Alpha and beta • Alpha in most normals – hyper and hypopigmetation of RPE • Beta more in glaucomas – atrophy of RPE and choriocapillaris • Alpha more peripheral if both present • Extent of beta corresponds with extent of rim loss PPA (Fingeret at al) Investigations • Disc photography (stereo?) – simple, cheap and very effective. Give patient a copy! • Field (SAP, FDT, SWAP ) - subjective, time consuming, late diagnosis • OCT / HRT / GDx – expensive, useful for progression? Visual Fields • Patients hate fields (nearly as much as puff tonometry) • Many differing machines and strategies • Get familiar with your machine, its limitations and the artifacts that come up • Know how to do your own fields or delegate to someone trained in them • Explain and instruct the test to patients (will not see every spot, may be gaps) Visual Fields • Don’t set the patient up and then leave, get coffee, make phone calls. • Quiet and dark room • Let patients know that they can stop and restart. Make sure they are comfortable • Let them know that all doesn’t depend on one field test (may need 3 or 4 before a pattern is identified. A learning effect will be seen) • If they are tired, sleepy, not well or anxious then do it another day Visual Fields • Is it reliable? (correct patient, age, refraction, eye) • Test duration? • Is it reproducible? • Does it match the disc? • Does it look like glaucoma? Follow NFL pattern? • Make sure you are comparing tests of the same strategy (SITA Fast v Standard, 24-2 v 10-2 or 30-2) • Look for artifacts- lid, lens rim, pupil size, cataract Artifacts Lid Artifact Fell Asleep? Glaucoma? The other eye…. Where is the lesion? OCT in Glaucoma • • • • Most recent addition in disc and RNFL imaging Many now using it to image the disc and RNFL RNFL loss often precedes cupping Will detect damage before SAP (or FDT- Brusini P, Eye 2007 Feb) • How useful is/will it be to detect change in the RNFL thickness ? Fast RNFL Analysis Three 3.4mm diameter circle scans in 1.92 secs allow all retinal nerve fibres to be imaged Acquires 768 A-scans 3* 256 A-scans per circular scan Ocular Hypertension Moderate glaucoma (MD -9.06) Optic Nerve Stress